Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2,500 | 1 | 51.5% |
| Food and Beverage | $2,351 | 95 | 48.4% |
| Education | $7.34 | 1 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $2,619 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $969.45 | 17 | $0 (2019) |
| Novo Nordisk Inc | $437.74 | 43 | $0 (2019) |
| Lilly USA, LLC | $359.24 | 13 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $250.36 | 9 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $119.99 | 1 | $0 (2018) |
| PFIZER INC. | $55.50 | 4 | $0 (2018) |
| Amgen Inc. | $31.07 | 2 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $16.31 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $848.94 | 36 | AstraZeneca Pharmaceuticals LP ($377.78) |
| 2018 | $3,927 | 60 | Merck Sharp & Dohme Corporation ($2,537) |
| 2017 | $82.55 | 1 | AstraZeneca Pharmaceuticals LP ($82.55) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $102.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2019 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Diabetes | ||||||
| 10/24/2019 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Diabetes | ||||||
| 10/21/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2019 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Diabetes | ||||||
| 09/04/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: DIABETES | ||||||
| 08/30/2019 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Diabetes | ||||||
| 08/28/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: DIABETES | ||||||
| 08/13/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/10/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Bone Health | ||||||
| 07/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY XR | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: DIABETES | ||||||
| 07/03/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
| 07/03/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $2.53 | General |
| Category: Diabetes | ||||||
| 07/03/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: Diabetes | ||||||
| 06/26/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DIABETES | ||||||
| 06/19/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $55.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/14/2019 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
| 06/13/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Diabetes | ||||||
| 05/22/2019 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Diabetes | ||||||
| 05/15/2019 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Diabetes | ||||||
| 05/08/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Diabetes | ||||||
| 04/26/2019 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate,Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and Adults With Persistent Asthma Protocol No. P06241 also known as P202 | Merck Sharp & Dohme Corporation | $2,500 | 1 |
About Dr. Clarita Ketels, DO
Dr. Clarita Ketels, DO is a Internal Medicine healthcare provider based in Lakeland, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417975145.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clarita Ketels, DO has received a total of $4,858 in payments from pharmaceutical and medical device companies, with $848.94 received in 2019. These payments were reported across 97 transactions from 9 companies. The most common payment nature is "" ($2,500).
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Lakeland, FL
- Active Since 07/18/2006
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417975145
Products in Payments
- DULERA (Drug) $2,500
- FARXIGA (Drug) $761.90
- Ozempic (Drug) $276.86
- TRULICITY (Drug) $240.12
- JARDIANCE (Drug) $218.84
- BYDUREON (Drug) $207.55
- Victoza (Drug) $160.88
- ELIQUIS (Drug) $119.99
- BASAGLAR (Drug) $119.12
- STEGLATRO (Drug) $55.33
- CHANTIX (Drug) $40.24
- JANUVIA (Drug) $37.12
- PNEUMOVAX 23 (Biological) $26.18
- Prolia (Biological) $18.16
- SPIRIVA RESPIMAT (Drug) $16.54
- Livalo (Drug) $16.31
- LYRICA (Drug) $15.26
- TRADJENTA (Drug) $14.98
- EVENITY (Biological) $12.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lakeland
Dr. Anurag Singh, Md, MD
Internal Medicine — Payments: $27,773
Guillermo Vasquez, Md, MD
Internal Medicine — Payments: $19,999
Stephen Swengros, Md, MD
Internal Medicine — Payments: $16,512
Dr. Lilliam Ayala Garcia, Md, MD
Internal Medicine — Payments: $12,595
Chau Nguyen, Md, MD
Internal Medicine — Payments: $12,125
Edward Baffoe-Bonnie, Md, MD
Internal Medicine — Payments: $10,942